Skip to content

Clinical trials

Completed Phase 2/3 Hepatitis C trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 2/3 Status: Completed Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20051
20062
20091
20101
20112
20132
20143
20154
20161
20171
20191
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie6
Merck Sharp & Dohme LLC3
Aga Khan University1
Biocad1
Centers for Disease Control and Prevention1
Egyptian Liver Hospital1
Foundation for Liver Research1
Icahn School of Medicine at Mount Sinai1
MIPO Clinic1
Muhammad Radzi Abu Hassan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C25
Hepatitis C, Chronic7
HIV Infections4
Acquired Immunodeficiency Syndrome2
Cryoglobulinemia1
Fibrosis1
Hepatitis1
Liver Cirrhosis1
Neoplasms1
Neutropenia1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.